Functional interplay between TFIIH and KAT2A regulates higher-order chromatin structure and class II gene expression.
Acetylation
CRISPR-Associated Protein 9
/ genetics
CRISPR-Cas Systems
Cell Line, Tumor
Chromatin
/ chemistry
Cockayne Syndrome
/ genetics
Fibroblasts
/ cytology
Gene Editing
Gene Expression Regulation
Histone Acetyltransferases
/ antagonists & inhibitors
Histones
/ genetics
Humans
Models, Biological
Osteoblasts
/ cytology
Primary Cell Culture
Protein Subunits
/ genetics
RNA, Guide, Kinetoplastida
/ genetics
RNA, Small Interfering
/ genetics
Signal Transduction
Transcription Factor TFIIH
/ genetics
Transcription Initiation, Genetic
Xeroderma Pigmentosum
/ genetics
Journal
Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555
Informations de publication
Date de publication:
20 03 2019
20 03 2019
Historique:
received:
28
05
2018
accepted:
01
03
2019
entrez:
22
3
2019
pubmed:
22
3
2019
medline:
4
4
2019
Statut:
epublish
Résumé
The TFIIH subunit XPB is involved in combined Xeroderma Pigmentosum and Cockayne syndrome (XP-B/CS). Our analyses reveal that XPB interacts functionally with KAT2A, a histone acetyltransferase (HAT) that belongs to the hSAGA and hATAC complexes. XPB interacts with KAT2A-containing complexes on chromatin and an XP-B/CS mutation specifically elicits KAT2A-mediated large-scale chromatin decondensation. In XP-B/CS cells, the abnormal recruitment of TFIIH and KAT2A to chromatin causes inappropriate acetylation of histone H3K9, leading to aberrant formation of transcription initiation complexes on the promoters of several hundred genes and their subsequent overexpression. Significantly, this cascade of events is similarly sensitive to KAT2A HAT inhibition or to the rescue with wild-type XPB. In agreement, the XP-B/CS mutation increases KAT2A HAT activity in vitro. Our results unveil a tight connection between TFIIH and KAT2A that controls higher-order chromatin structure and gene expression and provide new insights into transcriptional misregulation in a cancer-prone DNA repair-deficient disorder.
Identifiants
pubmed: 30894545
doi: 10.1038/s41467-019-09270-2
pii: 10.1038/s41467-019-09270-2
pmc: PMC6426930
doi:
Substances chimiques
Chromatin
0
Histones
0
Protein Subunits
0
RNA, Guide
0
RNA, Small Interfering
0
Transcription Factor TFIIH
148710-81-0
Histone Acetyltransferases
EC 2.3.1.48
KAT2A protein, human
EC 2.3.1.48
CRISPR-Associated Protein 9
EC 3.1.-
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1288Subventions
Organisme : European Research Council
ID : 340551
Pays : International
Références
Nat Rev Genet. 2011 Nov 03;12(12):833-45
pubmed: 22048664
Mol Cell. 2002 Nov;10(5):1163-74
pubmed: 12453423
EMBO Rep. 2002 Mar;3(3):224-9
pubmed: 11882541
J Cell Biol. 2012 Apr 16;197(2):267-81
pubmed: 22492724
Curr Opin Genet Dev. 2003 Jun;13(3):239-45
pubmed: 12787785
Oncogene. 2012 Nov 8;31(45):4803-9
pubmed: 22249246
Protein Expr Purif. 1997 Mar;9(2):153-8
pubmed: 9056480
Cold Spring Harb Perspect Biol. 2010 Aug;2(8):a000794
pubmed: 20591991
PLoS Genet. 2016 Feb 04;12(2):e1005791
pubmed: 26845027
Exp Cell Res. 1986 Feb;162(2):530-8
pubmed: 3002824
J Cell Biol. 1999 Jun 28;145(7):1341-54
pubmed: 10385516
Chem Biol. 2014 Mar 20;21(3):398-407
pubmed: 24508195
J Cell Biol. 2014 Sep 1;206(5):589-98
pubmed: 25154395
Nat Genet. 2004 Jul;36(7):714-9
pubmed: 15220921
Res Microbiol. 2011 Jan;162(1):19-26
pubmed: 20863882
PLoS One. 2012;7(5):e36960
pubmed: 22615856
J Am Acad Dermatol. 1993 Nov;29(5 Pt 2):883-9
pubmed: 8408834
Biochimie. 2003 Nov;85(11):1101-11
pubmed: 14726016
Nat Genet. 2008 Jul;40(7):897-903
pubmed: 18552846
Hum Mol Genet. 1999 Jun;8(6):1125-33
pubmed: 10332046
Am J Hum Genet. 1994 Feb;54(2):191-200
pubmed: 8304337
Nat Rev Mol Cell Biol. 2009 Apr;10(4):243-54
pubmed: 19277046
Biochemistry. 2009 Mar 31;48(12):2839-48
pubmed: 19199647
J Cell Biol. 2001 Dec 10;155(6):911-21
pubmed: 11739404
Mol Cell Biol. 1990 Jun;10(6):2570-81
pubmed: 2111438
Oncogene. 2007 Aug 13;26(37):5341-57
pubmed: 17694077
Genes Dev. 2012 Mar 15;26(6):527-41
pubmed: 22426530
Curr Opin Struct Biol. 2011 Dec;21(6):767-74
pubmed: 22014650
Am J Hum Genet. 1996 Feb;58(2):263-70
pubmed: 8571952
PLoS One. 2007 Mar 21;2(3):e316
pubmed: 17375202
Nature. 2007 May 24;447(7143):413-7
pubmed: 17522674
Mol Cell. 2010 Apr 9;38(1):54-66
pubmed: 20385089
Mol Cell. 2007 Apr 27;26(2):245-56
pubmed: 17466626
Hum Mutat. 2006 Nov;27(11):1092-103
pubmed: 16947863
Nat Rev Mol Cell Biol. 2012 May 10;13(6):343-54
pubmed: 22572993
Angew Chem Int Ed Engl. 2004 Jul 26;43(30):3974-6
pubmed: 15274229
Curr Opin Cell Biol. 2010 Jun;22(3):374-82
pubmed: 20363118
PLoS Biol. 2006 Mar;4(3):e67
pubmed: 16494529
Annu Rev Biochem. 2016 Jun 2;85:265-90
pubmed: 27294439
J Biol Chem. 2015 Nov 27;290(48):28997-9009
pubmed: 26468280
Sci Rep. 2014 Jan 29;4:3917
pubmed: 24472778
Oncogene. 2005 Feb 17;24(8):1359-74
pubmed: 15608684